buthionine sulfoximine glutathione The synthesis inhibitor synergistically enhanced melphalan activity against preclinical models of multiple myeloma synthesis inhibitor that activates oxidative stress Sigma-Aldrich ᴅʟ-Buthionine-sulfoximine, CAS 5072-26-4, ≥99.0%
Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S Transferase Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () Preclinical evaluation of azathioprine plus Development of a mouse model expressing a bifunctional glutathione synthesizing enzyme to study glutathione limitation in vivo Journal of Biological Chemistry Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



